Valuation : Illumina, Inc.

Market Cap 31.28B 26.98B 25.38B 23.12B 43.48B 2,968B 43.71B 300B 117B 1,510B 117B 115B 5,007B P/E 2026 *
41.8x
P/E 2027 * 35.4x
Enterprise Value 31.52B 27.19B 25.58B 23.3B 43.82B 2,992B 44.06B 302B 118B 1,522B 118B 116B 5,046B EV / Sales 2026 *
6.82x
EV / Sales 2027 * 6.22x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day-3.04%
1 week-7.94%
Current month-3.04%
1 month+0.99%
3 months+25.99%
6 months+54.05%
Current year+57.92%
1 week 206.82
Extreme 206.82
231.81
1 month 186.64
Extreme 186.64
231.81
Current year 112.65
Extreme 112.65
231.81
1 year 88
Extreme 88
231.81
3 years 68.7
Extreme 68.7
231.81
5 years 68.7
Extreme 68.7
471.1
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26
Corvex Management LP
SellCompany -138,379 0.0915%
25/08/26 Other

Director

0 0%
21/08/26
Corvex Management LP
SellCompany -299,336 0.1978%
Change 5-day change 1-year change 3-year change Capi.($)
-3.04%-7.94%+107.21%+22.96% 31.28B
-2.69%-4.40%+21.87%+7.77% 222B
-3.10%-4.19%+0.54%-22.09% 145B
-2.02%-0.70%-21.98%+18.96% 130B
-0.46%-3.57%-54.43%-10.33% 69.68B
-0.01%-0.14%+11.56%+18.80% 52.3B
-0.19%-1.01%-17.61%-14.19% 50.71B
-2.36%-3.13%+19.31%+22.98% 42.28B
-2.12%-2.08%+34.47%+44.42% 39.87B
-3.64%-2.21%-15.72%+45.34% 33.37B
Average -1.67%-1.54%+8.52%+13.46% 81.74B
Weighted average by Cap. -1.68%-1.69%+3.68%+6.73%

Financials

2026 *2027 *
Net sales 4.62B 3.99B 3.75B 3.42B 6.43B 439B 6.46B 44.36B 17.27B 223B 17.36B 16.99B 740B 4.91B 4.24B 3.98B 3.63B 6.83B 466B 6.86B 47.11B 18.34B 237B 18.44B 18.04B 786B
Net income 760M 656M 617M 562M 1.06B 72.16B 1.06B 7.29B 2.84B 36.71B 2.85B 2.79B 122B 891M 769M 723M 659M 1.24B 84.58B 1.25B 8.55B 3.33B 43.03B 3.35B 3.27B 143B
Net Debt 246M 212M 200M 182M 342M 23.35B 344M 2.36B 919M 11.88B 924M 904M 39.38B -729M -629M -592M -539M -1.01B -69.19B -1.02B -6.99B -2.72B -35.19B -2.74B -2.68B -117B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
01/09/26 US$207.13 -3.04% 1,501,398
31/08/26 US$213.63 -0.91% 2,017,763
28/08/26 US$215.59 -5.31% 1,791,898
27/08/26 US$227.69 +1.27% 1,937,242
26/08/26 US$224.84 -0.07% 1,714,494
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
207.13USD
Average target price
198.89USD
Spread / Average Target
-3.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock